Armstrong Advisory Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Armstrong Advisory Group's MRNA Position: Q3 2026 in Review
Armstrong Advisory Group held its Moderna (MRNA) position steady in Q3 2026 at 263 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #429.
Armstrong Advisory Group first reported a position in MRNA in Q4 2022 and has held it in 16 quarters since. 962 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Armstrong Advisory Group held 263 shares of Moderna worth $50.6K as of Q3 2026.
- Armstrong Advisory Group left its Moderna share count unchanged in Q3 2026.
- Moderna made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #429 holding.
- Armstrong Advisory Group first reported a position in Moderna in Q4 2022 and has held it in 16 quarters since.
- 962 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.